EagleClaw Capital Management’s Teva Pharmaceuticals TEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
2018
Q3
$253K Sell
2018
Q2
$287K Sell
2018
Q1
$212K Sell
2017
Q4
$258K Sell
2017
Q3
$271K Sell
2017
Q2
$545K Hold
2017
Q1
$529K Hold
2016
Q4
$600K Sell
2016
Q3
$804K Buy
2016
Q2
$471K Sell
2016
Q1
$567K Sell
2015
Q4
$1.3M Sell
2015
Q3
$1.14M Sell
2015
Q2
$1.2M Sell
2015
Q1
$1.28M Hold
2014
Q4
$1.19M Hold
2014
Q3
$1.11M Hold
2014
Q2
$1.08M Hold
2014
Q1
$1.09M Buy